Impact of long-term statin treatment on coronary plaque composition at angiographically severe lesions: A nonrandomized study of the history of long-term statin treatment before coronary angioplasty

Clinical Therapeutics

Volumn 31, Issue 1, 2009, Pages 64-73

  Miyagi, Motohiro ^a   Ishii, Hideki ^a   Murakami, Ryuichiro ^a   Isobe, Satoshi ^a   Hayashi, Mutsuharu ^a   Amano, Tetsuya ^a   Arai, Kosuke ^a   Ohashi, Taiki ^a   Uetani, Tadayuki ^a   Matsubara, Tatsuaki ^b   Murohara, Toyoaki ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b AICHI GAKUIN UNIVERSITY   (Japan)

Author keywords

integrated backscatter intravascular ultrasound; percutaneous coronary intervention; statin

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ATORVASTATIN; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FLUINDOSTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; LIPID; PITAVASTATIN; PRAVASTATIN; SIMVASTATIN; SULFONYLUREA;

AGED; ANGIOGRAPHY; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CORONARY ARTERY OBSTRUCTION; ELECTRONIC MEDICAL RECORD; FEMALE; HISTORY; HUMAN; HUMAN TISSUE; HYPERLIPIDEMIA; INFORMATION PROCESSING; INTRAVASCULAR ULTRASOUND; JAPAN; LIPID BLOOD LEVEL; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PERCUTANEOUS CORONARY INTERVENTION; PREVALENCE; STABLE ANGINA PECTORIS; THERAPY EFFECT; TRANSLUMINAL CORONARY ANGIOPLASTY; UNIVERSITY HOSPITAL;

AGED; ANGINA PECTORIS; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY ANGIOGRAPHY; CORONARY STENOSIS; FEMALE; HOSPITALS, UNIVERSITY; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; JAPAN; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; TIME FACTORS;

EID: 60349122636     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/j.clinthera.2009.01.002     Document Type: Article

References (26)

1. Roelandt J.R., di Mario C., Pandian N.G., et al. Three-dimensional reconstruction of intracoronary ultrasound images. Rationale, approaches, problems, and directions. Circulation 90 (1994) 1044-1055
2. von Birgelen C., de Vrey E.A., Mintz G.S., et al. ECG-gated three-dimensional intravascular ultrasound: Feasibility and reproducibility of the automated analysis of coronary lumen and atherosclerotic plaque dimensions in humans. Circulation 96 (1997) 2944-2952
3. Nissen S.E., and Yock P. Intravascular ultrasound: Novel pathophysiological insights and current clinical applications. Circulation 103 (2001) 604-616
4. Kawasaki M., Takatsu H., Noda T., et al. In vivo quantitative tissue characterization of human coronary arterial plaques by use of integrated backscatter intravascular ultrasound and comparison with angioscopic findings. Circulation 105 (2002) 2487-2492
5. Sano K., Kawasaki M., Ishihara Y., et al. Assessment of vulnerable plaques causing acute coronary syndrome using integrated backscatter intravascular ultrasound. J Am Coll Cardiol 47 (2006) 734-741
6. Uetani T., Amano T., Ando H., et al. The correlation between lipid volume in the target lesion, measured by integrated backscatter intravascular ultrasound, and post-procedural myocardial infarction in patients with elective stent implantation. EurHeartJ 29 (2008) 1714-1720
7. Herrmann J., Lerman A., Baumgart D., et al. Preprocedural statin medication reduces the extent of penprocedural non-Q-wave myocardial infarction. Circulation 106 (2002) 2180-2183
8. Briguon C., Colombo A., Airoldi F., et al. Statin administration before percutaneous coronary intervention: Impact on penprocedural myocardial infarction. Eur Heart J 25 (2004) 1822-1828
9. Mulukutla S.R., Marroqum O.C., Smith C., et al. Effect of statin therapy prior to elective percutaneous coronary intervention on frequency of penprocedural myocardial injury. Am J Cardiol 94 (2004) 1363-1366
10. Pascen V., Patti G., Nusca A., et al., ARMYDA Investigators. Randomized trial of atorvastatin for reduction of myocardial damage during coronary intervention: Results from the ARMYDA (Atorvastatin for Reduction of MYo-cardial Damage during Angioplasty) study. Circulation 110 (2004) 674-678
11. Simoons M.L., van den Brand M., Lincoff M., et al. Minimal myocardial damage during coronary intervention is associated with impaired outcome. Eur Heart J 20 (1999) 11121119
12. Tardiff B.E., Cahff R.M., Tcheng J.E., et al. Clinical outcomes after detection of elevated cardiac enzymes in patients undergoing percutaneous intervention. IMPACT-II Investigators. Integnlin (eptifibatide) to Minimize Platelet Aggregation and Coronary Thrombosis-ll. J Am Coll Cardiol 33 (1999) 88-96
13. Herrmann J., Von Birgelen C., Haude M., et al. Prognostic implications of cardiac troponin T increase following stent implantation. Heart 87 (2002) 549-553
14. Nissen S.E., Tuzcu E.M., Schoenhagen P., et al., REVERSAL Investigators. Effect of intensive compared with moderate hpid-lowering therapy on progression of coronary atherosclerosis: A randomized controlled trial. JAMA 291 (2004) 1071-1080
15. Kawasaki M., Sano K., Okubo M., et al. Volumetric quantitative analysis of tissue characteristics of coronary plaques after statin therapy using three-dimensional integrated back-scatter intravascular ultrasound. J Am Coll Cardiol 45 (2005) 1946-1953
16. Davies M.J., Richardson P.D., Woolf N., et al. Risk of thrombosis in human atherosclerotic plaques: Role of extracellular lipid, macrophage, and smooth muscle cell content. Br Heart} 69 (1993) 377-381
17. Fernández-Ortiz A., Badimon J.J., Falk E., et al. Characterization of the relative thrombogenicity of atherosclerotic plaque components: Implications for consequences of plaque rupture. J Am Coll Cardiol 23 (1994) 1562-1569
18. R. Gubler, editor. World Medical Association Declaration of Helsinki: Ethical Principles for Medical Research Involving Human Subjects [WMA Web site]. http://www.wma.net/e7policy/b3.htm Accessed November 30, 2008
19. Ryan T.J., Bauman W.B., Kennedy J.W., et al. Guidelines for percutaneous transluminal coronary angioplasty. A report of the American Heart Association/American College of Cardiology Task Force on Assessment of Diagnostic and Therapeutics Cardiovascular Procedures (Committee on Percutaneous Transluminal Coronary Angioplasty). Circulation 88 (1993) 2987-3007
20. Mintz G.S., Nissen S.E., Anderson W.D., et al. American College of Cardiology Clinical Expert Consensus Document on Standards for Acquisition, Measurement and Reporting of Intravascular Ultrasound Studies (IVUS). A report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents. J Am Coll Cardiol 37 (2001) 1478-1492
21. Jensen L.O., Thayssen P., Pedersen K.E., et al. Regression of coronary atherosclerosis by simvastatin: A serial intravascular ultrasound study. Circulation 110 (2004) 265-270
22. Okazaki S., Yokoyama T., Miyauchi K., et al. Early statin treatment in patients with acute coronary syndrome: Demonstration of the beneficial effect on atherosclerotic lesions by serial volumetric intravascular ultrasound analysis during half a year after coronary event: The ESTABLISH study. Circulation 110 (2004) 1061-1068
23. Tanaka A., Kawarabayashi T., Nishibon Y., et al. No-reflow phenomenon and lesion morphology in patients with acute myocardial infarction. Circulation 105 (2002) 2148-2152
24. Ishn H., Ichimiya S., Kanashiro M., et al. Effects of receipt of chronic statin therapy before the onset of acute myocardial infarction: A retrospective study in patients undergoing primary percutaneous coronary intervention. Clin Ther 28 (2006) 1812-1819
25. Iwakura K., Ito H., Kawano S., et al. Chronic pretreatment of statins is associated with the reduction ofthe no-reflow phenomenon in the patients with reperfused acute myocardial infarction. Eur Heart J 27 (2006) 534-539
26. Liao J.K. Clinical implications for statin pleiotropy. Curr Opin Lipidol 16 (2005) 624-629